M Arockia Babu - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

M Arockia Babu

Showing results (1-10 of 60) with videos related to

Pageof 6

Sort By:

Chemico-Biological Interactions|July 2, 2026

Interactions-Guided Blueprint of Acetylcholinesterase Binding: A Review on Structural and Molecular DeterminantsRam Kumar, Suman Sinha, M Arockia Babu

Bioorganic & Medicinal Chemistry|July 25, 2025

Structural insights for peptide and small molecules based drug discovery targeting the KEAP1 Kelch domain: A reviewSuman Sinha, Ram Kumar, Niraj Kumar Singh, et al.

Journal of Biomolecular Structure & Dynamics|April 9, 2019

4-Bromo-4'-chloro pyrazoline analog of curcumin augmented anticancer activity against human cervical cancer, HeLa cells: <i>in silico</i>-guided analysis, synthesis, and <i>in vitro</i> cytotoxicityMonika Chaudhary, Neeraj Kumar, Ashish Baldi, et al.

Bioorganic & Medicinal Chemistry|November 5, 2002

Development of 3D-QSAR models for 5-lipoxygenase antagonists: chalconesM Arockia Babu, Neeraj Shakya, Philip Prathipati, et al.

Journal of Biomolecular Structure & Dynamics|February 21, 2019

Chloro and bromo-pyrazole curcumin Knoevenagel condensates augmented anticancer activity against human cervical cancer cells: design, synthesis, <i>in silico</i> docking and <i>in vitro</i> cytotoxicity analysisMonika Chaudhary, Neeraj Kumar, Ashish Baldi, et al.

Journal of Molecular Neuroscience : MN|October 28, 2024

Signaling Pathways Concerning Mitochondrial Dysfunction: Implications in Neurodegeneration and Possible Molecular TargetsYati Sharma, Jeetendra Kumar Gupta, M Arockia Babu, et al.

Archives of Pharmacal Research|December 28, 2023

Antibody-drug conjugates in cancer therapy: innovations, challenges, and future directionsShivangi Kumari, Sonam Raj, M Arockia Babu, et al.

Current Genomics|May 21, 2026

Understanding the Evolutionary Adaptations and the Associated Functional Dynamics of Diatom <i>Cyclotella Cryptica</i>: A Chloroplast Genome-wide Comparative StudyPankaj Kumar Singh, Baskaran Srinivasan, M Arockia Babu, et al.

Clinica Chimica Acta; International Journal of Clinical Chemistry|May 27, 2025

MUC1 as a diagnostic biomarker and siRNA-based therapeutic target in breast cancer: A clinical chemistry perspectiveSurya Nath Pandey, M Arockia Babu, Haider Ali, et al.

Archiv Der Pharmazie|January 20, 2026

Retrospection of the USFDA-Approved Halogenated Drugs and Their Implication in Medicinal Chemistry and Drug Discovery: A Perspective of Approved Drugs Between 2019 and 2024Nemat Ali, Fahad T Alotaibi, M Arockia Babu, et al.

Pageof 6

Search research articles

Showing results (1-10 of 60) with videos related to

Sort By:

Pageof 6

Chemico-Biological Interactions|July 2, 2026

Interactions-Guided Blueprint of Acetylcholinesterase Binding: A Review on Structural and Molecular DeterminantsRam Kumar, Suman Sinha, M Arockia Babu

Bioorganic & Medicinal Chemistry|July 25, 2025

Structural insights for peptide and small molecules based drug discovery targeting the KEAP1 Kelch domain: A reviewSuman Sinha, Ram Kumar, Niraj Kumar Singh, et al.

Journal of Biomolecular Structure & Dynamics|April 9, 2019

4-Bromo-4'-chloro pyrazoline analog of curcumin augmented anticancer activity against human cervical cancer, HeLa cells: <i>in silico</i>-guided analysis, synthesis, and <i>in vitro</i> cytotoxicityMonika Chaudhary, Neeraj Kumar, Ashish Baldi, et al.

Bioorganic & Medicinal Chemistry|November 5, 2002

Development of 3D-QSAR models for 5-lipoxygenase antagonists: chalconesM Arockia Babu, Neeraj Shakya, Philip Prathipati, et al.

Journal of Biomolecular Structure & Dynamics|February 21, 2019

Chloro and bromo-pyrazole curcumin Knoevenagel condensates augmented anticancer activity against human cervical cancer cells: design, synthesis, <i>in silico</i> docking and <i>in vitro</i> cytotoxicity analysisMonika Chaudhary, Neeraj Kumar, Ashish Baldi, et al.

Journal of Molecular Neuroscience : MN|October 28, 2024

Signaling Pathways Concerning Mitochondrial Dysfunction: Implications in Neurodegeneration and Possible Molecular TargetsYati Sharma, Jeetendra Kumar Gupta, M Arockia Babu, et al.

Archives of Pharmacal Research|December 28, 2023

Antibody-drug conjugates in cancer therapy: innovations, challenges, and future directionsShivangi Kumari, Sonam Raj, M Arockia Babu, et al.

Current Genomics|May 21, 2026

Understanding the Evolutionary Adaptations and the Associated Functional Dynamics of Diatom <i>Cyclotella Cryptica</i>: A Chloroplast Genome-wide Comparative StudyPankaj Kumar Singh, Baskaran Srinivasan, M Arockia Babu, et al.

Clinica Chimica Acta; International Journal of Clinical Chemistry|May 27, 2025

MUC1 as a diagnostic biomarker and siRNA-based therapeutic target in breast cancer: A clinical chemistry perspectiveSurya Nath Pandey, M Arockia Babu, Haider Ali, et al.

Archiv Der Pharmazie|January 20, 2026

Retrospection of the USFDA-Approved Halogenated Drugs and Their Implication in Medicinal Chemistry and Drug Discovery: A Perspective of Approved Drugs Between 2019 and 2024Nemat Ali, Fahad T Alotaibi, M Arockia Babu, et al.

Pageof 6